GGrantIndex
← Leaderboards

Eugene A Woltering

Tulane University Of Louisiana

Google Scholar ↗PubMed ↗ORCID ↗
$73,643
Attributed
$73,643
Total exposure
18
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $21.3K · FY2005–06
$25K$18.8K$12.5K$6.3K$0
'05
'06

Funding mix

By agency

NIH$73,643 · 18

By mechanism

M01$73,643 · 18

Top collaborators

No co-investigators on record.

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

Research focus

Clinical ResearchHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyBreast NeoplasmsFemaleDoxorubicinCyclophosphamideCombination ChemotherapyPaclitaxelDrug Screening /EvaluationBreast SurgeryNeoplasm /Cancer SurgeryPatient Oriented ResearchClinical TrialsTamoxifenAntineoplasticsCombination Cancer TherapyNeoplasm /Cancer Radiation TherapyMonocyteBone MetabolismMethotrexateEnzyme Linked Immunosorbent AssayDrug Adverse Effect

Grant awards (26)

THREE CHEMOTHERAPY REGIMENS IN WOMEN WITH NODE-POSITIVE BREAST CANCER$5,634
M01 · FY2006 · RR · contact PI
TRIAL COMPARING SIX CYLES OF FEC TO FOUR CYCLES OF AC IN BREAST CANCER$4,080
M01 · FY2006 · RR · contact PI
TRIAL COMPARING 5-FU PLUS LEUCOVORIN AND OXALIPLATIN IN CARCINOMA OF THE COLON$2,914
M01 · FY2006 · RR · contact PI
TRIAL TO COMPARE ADJUVANT ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN BREAST CANCER PTS$2,525
M01 · FY2006 · RR · contact PI
NSABP B-27:TRIAL COMPARING PREOP AC TO AC FOLLOWED BY TAXOTERE/CANCER OF BREAST$389
M01 · FY2006 · RR · contact PI
ANGIOGENIC ENDOTHELIAL CELL DETECTION IN PERIPHERAL CIRCULATION IN METASTATIC DS$194
M01 · FY2006 · RR · contact PI
TRIAL COMPARING ADJUVANT CLODRONATE THERAPY VERSUS PLACEBO EARLY BREAST CANCER$194
M01 · FY2006 · RR · contact PI
TRIAL TO COMPARE ADJUVANT ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN BREAST CANCER PTS$15,234
M01 · FY2005 · RR
TRIAL COMPARING 5-FU PLUS LEUCOVORIN AND OXALIPLATIN IN CARCINOMA OF THE COLON$2,366
M01 · FY2005 · RR
TRIAL COMPARING SIX CYLES OF FEC TO FOUR CYCLES OF AC IN BREAST CANCER$1,923
M01 · FY2005 · RR
TRIAL COMPARING ADJUVANT CLODRONATE THERAPY VERSUS PLACEBO EARLY BREAST CANCER$1,331
M01 · FY2005 · RR
NSABP B-27:TRIAL COMPARING PREOP AC TO AC FOLLOWED BY TAXOTERE/CANCER OF BREAST$306
M01 · FY2005 · RR
TRIAL COMPARING AC-T TO AC-T+H IN NODE-POSITIVE BREAST CANCER PATIENTS$148
M01 · FY2005 · RR
Trial to Compare Adjuvant Adriamycin &Cyclophosphamide$16,612
M01 · FY2004 · RR
Trial Comparing AC-T to AC-T+H in Node+ Breast Cancer$8,306
M01 · FY2004 · RR
Trial Comparing 5-FU Plus Leucovorin and Oxaliplatin$5,302
M01 · FY2004 · RR
Trial Comparing Adjuvant Clodronate Therapy Vs Placebo$5,125
M01 · FY2004 · RR
NSABP B-27:Trial Comparing Preop AC to AC Followed by Taxotere/Cancer of Breast$1,060
M01 · FY2004 · RR
NSABP B 23--SHORT INTENSIVE AC/TAMOXIFEN W/ CMP PLUS TAMOXIFEN IN BREAST CANCER$0
M01 · FY2001 · RR
OCTREOTIDE PLUS TAMOXIFEN IN BREAST CANCER$0
M01 · FY2001 · RR
NSABP B-27--TRIAL COMPARING PREOP AC TO AC FOLLOWED BY TAXOTERE IN BREAST CANCER$0
M01 · FY2001 · RR
NSABP28--WORTH OF TAXOL FOLLOWING ADRIAMYCIN IN BREAST CANCER$0
M01 · FY2001 · RR
NSABP B 23--SHORT INTENSIVE AC/TAMOXIFEN W/ CMP PLUS TAMOXIFEN IN BREAST CANCER$0
M01 · FY2000 · RR
OCTREOTIDE PLUS TAMOXIFEN IN BREAST CANCER$0
M01 · FY2000 · RR
NSABP B-27--TRIAL COMPARING PREOP AC TO AC FOLLOWED BY TAXOTERE IN BREAST CANCER$0
M01 · FY2000 · RR
NSABP28--WORTH OF TAXOL FOLLOWING ADRIAMYCIN IN BREAST CANCER$0
M01 · FY2000 · RR